Coronavirus Disease (COVID-19) Updates

In response to the current outbreak of coronavirus disease (COVID-19) that was first reported from Wuhan, China, on December 31, 2019, Charles River has assembled a global team of internal experts who are closely monitoring the COVID-19 outbreak and its impact on employee safety and our business operations. To keep clients informed, we will post updates to this web page.

Charles River corporate headquarters

May 7, 2020 – As events related to COVID-19 continue to unfold, I wanted to again provide an update on our status. Charles River remains operational across all sites, adapting to developments as they occur. We are still monitoring the outbreak with our internal and external experts and assessing the impact on employee safety and business operations. Our locations around the world are doing an excellent job of providing protection for their employees while still meeting clients’ needs for research products and services.

While governments at various levels begin implementing a ‘return to business,’ the risk of infection remains present. To help prevent the spread of the virus while maintaining continued operations during this period, we are upholding our travel restrictions, strict visitor policies, and flexible work schedules with shift-work where appropriate. Employees who are able to work from home will continue to do so and, as always, everyone is being reminded of the importance of good hygiene practices.

Our global and site Business Continuity Plans are active, up to date, and helping our site-based operations, as well as associated logistics and support, to continue to meet our clients’ needs for planned and new projects, including work supporting COVID-19 research efforts. None of this would be possible without the work of our frontline employees – the very definition of essential. Without their commitment to Charles River’s mission, there is no way we would be able to partner with you so effectively in the search for healthier lives.

For the latest business continuity updates, continue to visit this page. For continued learning, our digital education page has many helpful resources for researchers and to find services to support COVID-19 research, visit our new research support web page. If you have any other questions, please reach out either to me or your sales representative.

Contact Us

Call us at:
United States and Canada: +1.877.CRIVER1 (+1.877.274.8371)

All other locations: 888.319.5343

Hours of coverage:
6 a.m.-6 p.m. ET

Email us at:
[email protected]


Related Resources

Business Operations Updates:

Compliance and Quality Assurance

Novel Coronavirus and Research Animals
(Updated April 28, 2020)

Visitor Notice
(Updated May 27, 2020)

COVID-19 UK Statement